Avado turns health care into continuous care

In ancient China, doctors were paid to keep their patients well. If a patient fell ill, the doctor didn’t get paid until they got better. We have gotten used to being continuously connected, so why does healthcare still revolve around an occasional face to face meeting with your doctor when something has already gone wrong?

Paying doctors to use digital records — Medicare finally does the right thing

Digital health records would be a great thing for the U.S. healthcare system, should doctors and hospitals ever adopt them widely. (Among other things, they’d likely cut down on medical errors and improve the quality of medical care.) Yet only about 10 percent of smaller physicians’ offices use them, because the upfront costs of implementing an electronic-records system are so daunting — and because the doctors themselves won’t tend to reap benefits from the investment for years, if not longer.

Roundup: Biogenerics bill in limbo, clashing data on health IT benefits, the RNAi boom, and more

House-Senate confrontation set over biogenerics — Late last month, a key group of senators reached agreement on legislative provisions that would authorize copycat versions of biotech drugs, which are typically complex proteins manufactured by genetically engineered cells (see details here and here). These provisions would finally put biotech drugs — which don’t face cut-rate competition once their key patents expire — on a par with traditional pharmaceuticals, and have been a long time in coming. They’re not perfect, but they’re about as good a compromise as we’re likely to see any time soon..

Andy Grove’s placebo pill for U.S. healthcare

Having survived prostate cancer and now facing a mild form of Parkinson’s disease, former Intel chairman Andy Grove has turned his analytical eye on the increasingly dysfunctional U.S. healthcare system.